{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["antioxidants defense", "inflammation", "kidney disease", "oxidative stress", "ozone", "ozone therapy"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36983907", "DateRevised": {"Year": "2023", "Month": "03", "Day": "31"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "03", "Day": "10"}], "ELocationID": ["752", "10.3390/life13030752"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "13", "Issue": "3", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "10"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "The Protective Role of Ozone Therapy in Kidney Disease: A Review.", "Abstract": {"AbstractText": ["Ozone (O<sub>3</sub>) is a reactive oxygen species (ROS) that can interact with cellular components and cause oxidative stress. Following said logic, if O<sub>3</sub> induces such a stressful milieu, how does it exert antioxidant functions? This is mediated by controlled toxicity produced by low concentrations of O<sub>3</sub>, which enhance the cell's suppliance of antioxidant properties without causing any further damage. Therapeutic concentrations vary extensively, although 50 \u00b5g/mL is commonly used in experimental and clinical procedures, given that augmented concentrations might work as germicides or cause endogenous damage. O<sub>3</sub> therapy has been shown to be effective when applied before or after traumatic renal procedures, whether caused by ischemia, xenobiotics, chronic damage, or other models. In this review, we focus on discussing the role of O<sub>3</sub> therapy in different models of kidney damage associated with fibrosis, apoptosis, oxidative stress, and inflammation. We integrate and report knowledge about O<sub>3</sub> in renal therapy, debunking skepticism towards unconventional medicine, explaining its proven therapeutic properties, and thus providing background for its use in further research as well as in clinical settings."]}, "AuthorList": [{"Identifier": ["0000-0001-9280-9859"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04360, Mexico."}, {"Identifier": [], "Affiliation": "Laboratory F-315, Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico, Mexico City 04510, Mexico."}], "LastName": "Delgadillo-Valero", "ForeName": "Luis Fernando", "Initials": "LF"}, {"Identifier": ["0000-0002-0690-4188"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory F-315, Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico, Mexico City 04510, Mexico."}, {"Identifier": [], "Affiliation": "Postgraduate in Biological Sciences, National Autonomous University of Mexico, Ciudad Universitaria, Mexico City 04510, Mexico."}], "LastName": "Hern\u00e1ndez-Cruz", "ForeName": "Estefani Yaquelin", "Initials": "EY"}, {"Identifier": ["0000-0001-6628-4411"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory F-315, Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico, Mexico City 04510, Mexico."}], "LastName": "Pedraza-Chaverri", "ForeName": "Jos\u00e9", "Initials": "J"}], "GrantList": [{"GrantID": "A1-S-7495", "Agency": "Consejo Nacional de Ciencia y Tecnolog\u00eda", "Country": ""}, {"GrantID": "IN200922", "Agency": "National Autonomous University of Mexico", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Pawlina W., Ross M. Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. 8th ed. Wolters Kluwer Health; Philadelphia, PA, USA: 2018."}, {"Citation": "Susantitaphong P., Cruz D.N., Cerda J., Abulfaraj M., Alqahtani F., Koulouridis I., Jaber B.L. World Incidence of AKI: A Meta-Analysis. Clin. J. Am. Soc. Nephrol. 2013;8:1482\u20131493. doi: 10.2215/CJN.00710113.", "ArticleIdList": ["10.2215/CJN.00710113", "PMC3805065", "23744003"]}, {"Citation": "Webster A.C., Nagler E.V., Morton R.L., Masson P. Chronic Kidney Disease. Lancet. 2017;389:1238\u20131252. doi: 10.1016/S0140-6736(16)32064-5.", "ArticleIdList": ["10.1016/S0140-6736(16)32064-5", "27887750"]}, {"Citation": "Ku E., Lee B.J., Wei J., Weir M.R. Hypertension in CKD: Core Curriculum 2019. Am. J. Kidney Dis. 2019;74:120\u2013131. doi: 10.1053/j.ajkd.2018.12.044.", "ArticleIdList": ["10.1053/j.ajkd.2018.12.044", "30898362"]}, {"Citation": "National Kidney Disease Education Program . Making Sense of CKD\u2014A Concise Guide for Managing Chronic Kidney Disease in the Primary Care Setting. NIH Publication; Bethesda, MD, USA: 2014. No. 14-7989."}, {"Citation": "Centers for Disease Control and Prevention (CDC) Estimated Hypertension Prevalence, Treatment, and Control among U.S. Adults. US Department of Health and Human Services; Atlanta, GA, USA: 2021."}, {"Citation": "CENETEC . Prevenci\u00f3n, Diagn\u00f3stico y Tratamiento de La Enfermedad Renal Cr\u00f3nica. CENETEC; Cuauht\u00e9moc, Mexico: 2012. Gu\u00eda de Referencia R\u00e1pida, Gu\u00eda de Pr\u00e1ctica Cl\u00ednica."}, {"Citation": "Kellum J.A., Romagnani P., Ashuntantang G., Ronco C., Zarbock A., Anders H.-J. Acute kidney injury. Nat. Rev. Dis. Prim. 2021;7:52. doi: 10.1038/s41572-021-00284-z.", "ArticleIdList": ["10.1038/s41572-021-00284-z", "34267223"]}, {"Citation": "Nordio M., Limido A., Maggiore U., Nichelatti M., Postorino M., Quintaliani G. Survival in Patients Treated by Long-term Dialysis Compared with the General Population. Am. J. Kidney Dis. 2012;59:819\u2013828. doi: 10.1053/j.ajkd.2011.12.023.", "ArticleIdList": ["10.1053/j.ajkd.2011.12.023", "22361043"]}, {"Citation": "De Vecchi A.F., Bamonti F., Novembrino C., Ippolito S., Guerra L., Lonati S., Salini S., Aman C.S., Scurati-Manzoni E., Cighetti G.M. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. Nephrol. Dial. Transplant. 2009;24:2524\u20132529. doi: 10.1093/ndt/gfp102.", "ArticleIdList": ["10.1093/ndt/gfp102", "19264746"]}, {"Citation": "KDIGO Guidelines Chapter 3: Management of progression and complications of CKD. Kidney Int. Suppl. 2013;3:73\u201390. doi: 10.1038/kisup.2012.66.", "ArticleIdList": ["10.1038/kisup.2012.66", "PMC4283680", "25598999"]}, {"Citation": "Honeycutt A.A., Segel J.E., Zhuo X., Hoerger T.J., Imai K., Williams D. Medical Costs of CKD in the Medicare Population. J. Am. Soc. Nephrol. 2013;24:1478\u20131483. doi: 10.1681/ASN.2012040392.", "ArticleIdList": ["10.1681/ASN.2012040392", "PMC3752941", "23907508"]}, {"Citation": "Mehta R.L., Cerd\u00e1 J., Burdmann E.A., Tonelli M., Garc\u00eda-Garc\u00eda G., Jha V., Susantitaphong P., Rocco M., Vanholder R., Sever M.S., et al. International Society of Nephrology\u2019s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): A human rights case for nephrology. Lancet. 2015;385:2616\u20132643. doi: 10.1016/S0140-6736(15)60126-X.", "ArticleIdList": ["10.1016/S0140-6736(15)60126-X", "25777661"]}, {"Citation": "Heim C., Glas K. Ozone I: Characteristics/Generation/Possible Applications. Brew. Sci. 2011;64:8\u201312."}, {"Citation": "Nogales C.G., Ferreira M.B., Lage-Marques J.L. Comparison of the Antimicrobial Activity of Three Different Concentrations of Aqueous Ozone on Pseudomonas Aeruginosa, Staphylococcus Aureus, and Entero-Coccus Faecalis\u2014In Vitro Study. Rev. Espa\u00f1ola Ozonoterapia. 2014;4:9\u201315."}, {"Citation": "Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. Oxford University Press; Oxford, UK: 2015."}, {"Citation": "Greene A.K., G\u00fczel-Seydim Z.B., Seydim A.C. Ozone in Food Processing. Wiley-Blackwell; Oxford, UK: 2012. Chemical and Physical Properties of Ozone; pp. 19\u201332."}, {"Citation": "Ma Q. Role of Nrf2 in Oxidative Stress and Toxicity. Annu. Rev. Pharmacol. Toxicol. 2013;53:401\u2013426. doi: 10.1146/annurev-pharmtox-011112-140320.", "ArticleIdList": ["10.1146/annurev-pharmtox-011112-140320", "PMC4680839", "23294312"]}, {"Citation": "Hidalgo-Tall\u00f3n F.J., Torres-Morera L.M., Baeza-Noci J., Carrillo-Izquierdo M.D., Pinto-Bonilla R. Updated Review on Ozone Therapy in Pain Medicine. Front. Physiol. 2022;13:840623. doi: 10.3389/fphys.2022.840623.", "ArticleIdList": ["10.3389/fphys.2022.840623", "PMC8904924", "35283802"]}, {"Citation": "Khan S.A., Smith N.L., Wilson A.L., Gandhi J., Vatsia S. Ozone therapy: An overview of pharmacodynamics, current research, and clinical utility. Med. Gas Res. 2017;7:212. doi: 10.4103/2045-9912.215752.", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Delgado-Roche L., Riera-Romo M., Mesta F., Hern\u00e1ndez-Matos Y., Barrios J.M., Mart\u00ednez-S\u00e1nchez G., Al-Dalaien S.M. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur. J. Pharmacol. 2017;811:148\u2013154. doi: 10.1016/j.ejphar.2017.06.017.", "ArticleIdList": ["10.1016/j.ejphar.2017.06.017", "28623000"]}, {"Citation": "Viebahn-H\u00e4nsler R., Fern\u00e1ndez O.S.L., Fahmy Z. Ozone in Medicine: The Low-Dose Ozone Concept\u2014Guidelines and Treatment Strategies. Ozone Sci. Eng. 2012;34:408\u2013424. doi: 10.1080/01919512.2012.717847.", "ArticleIdList": ["10.1080/01919512.2012.717847"]}, {"Citation": "Cenci A., Macchia I., La Sorsa V., Sbarigia C., Di Donna V., Pietraforte D. Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2. Front. Microbiol. 2022;13:871645. doi: 10.3389/fmicb.2022.871645.", "ArticleIdList": ["10.3389/fmicb.2022.871645", "PMC9069003", "35531273"]}, {"Citation": "Bocci V. Biological and Clinical Effects of Ozone. Has Ozone Therapy a Future in Medicine? Br. J. Biomed. Sci. 1999;56:270\u2013279.", "ArticleIdList": ["10795372"]}, {"Citation": "Huidobro E.J., Tagle R., Guzm\u00e1n A.M. Creatinina y Su Uso Para La Estimaci\u00f3n de La Velocidad de Filtraci\u00f3n Glomerular. Rev. Med. Chil. 2018;146:344\u2013350. doi: 10.4067/s0034-98872018000300344.", "ArticleIdList": ["10.4067/s0034-98872018000300344", "29999105"]}, {"Citation": "Xing B., Chen H., Wang L., Weng X., Chen Z., Li X. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury via modulation of the TLR4-NF-\u03baB pathway. Acta Cir. Bras. 2015;30:60\u201366. doi: 10.1590/S0102-86502015001000008.", "ArticleIdList": ["10.1590/S0102-86502015001000008", "25627272"]}, {"Citation": "Foglieni C., Fulgenzi A., Belloni D., Sciorati C., Ferrero E., Ferrero M.E. Ozonated autohemotherapy: Protection of kidneys from ischemia in rats subjected to unilateral nephrectomy. BMC Nephrol. 2011;12:61. doi: 10.1186/1471-2369-12-61.", "ArticleIdList": ["10.1186/1471-2369-12-61", "PMC3261102", "22081953"]}, {"Citation": "Chen H., Xing B., Liu X., Zhan B., Zhou J., Zhu H., Chen Z. Ozone Oxidative Preconditioning Protects the Rat Kidney from Reperfusion Injury: The Role of Nitric Oxide. J. Surg. Res. 2008;149:287\u2013295. doi: 10.1016/j.jss.2007.12.756.", "ArticleIdList": ["10.1016/j.jss.2007.12.756", "18262565"]}, {"Citation": "Jiang B., Su Y., Chen Q., Dong L., Zhou W., Li H., Wang Y. Protective Effects of Ozone Oxidative Postconditioning on Long-term Injury after Renal Ischemia/Reperfusion in Rat. Transplant. Proc. 2020;52:365\u2013372. doi: 10.1016/j.transproceed.2019.10.004.", "ArticleIdList": ["10.1016/j.transproceed.2019.10.004", "31898937"]}, {"Citation": "Wang L., Chen Z., Liu Y., Du Y., Liu X. Ozone oxidative postconditioning inhibits oxidative stress and apoptosis in renal ischemia and reperfusion injury through inhibition of MAPK signaling pathway. Drug Des. Dev. Ther. 2018;12:1293\u20131301. doi: 10.2147/DDDT.S164927.", "ArticleIdList": ["10.2147/DDDT.S164927", "PMC5968808", "29861623"]}, {"Citation": "Oztosun M., Akgul E.O., Cakir E., Cayci T., Uysal B., Ogur R., Ozcan A., Ozgurtas T., Guven A., Korkmaz A. The Effects of Medical Ozone Therapy on Renal Ischemia/Reperfusion Injury. Ren. Fail. 2012;34:921\u2013925. doi: 10.3109/0886022X.2012.692752.", "ArticleIdList": ["10.3109/0886022X.2012.692752", "22686108"]}, {"Citation": "Fern\u00e1ndez A., Gonz\u00e1lez L., Calunga J.L., Rodr\u00edguez S., Santos E. Ozone Postconditioning in Renal Ischaemia-Reperfusion Model. Functional and Morphological Evidences. Soc. Espa\u00f1ola Nefrol. 2011;31:379\u2013504.", "ArticleIdList": ["21738249"]}, {"Citation": "Wang L., Chen H., Liu X.-H., Chen Z.-Y., Weng X.-D., Qiu T., Liu L., Zhu H.-C. Ozone oxidative preconditioning inhibits renal fibrosis induced by ischemia and reperfusion injury in rats. Exp. Ther. Med. 2014;8:1764\u20131768. doi: 10.3892/etm.2014.2004.", "ArticleIdList": ["10.3892/etm.2014.2004", "PMC4218702", "25371729"]}, {"Citation": "Abbas A., Lichtman A., Pillai S. Cellular and Molecular Immunology. 10th ed. Elsevier; Edinburgh, UK: 2021."}, {"Citation": "Repetto M., Semprine J., Boveris A. Lipid Peroxidation. IntechOpen; London, UK: 2012. Lipid Peroxidation: Chemical Mechanism, Biological Implications and Analytical Determination.", "ArticleIdList": ["10.5772/45943"]}, {"Citation": "P\u00e9rez Fernandez R., Mart\u00edn Mateo M.C., De Vega L., Bustamante Bustamante J., Herrero M., Bustamante Munguira E. Antioxidant enzyme determination and a study of lipid peroxidation in renal transplantation. Ren. Fail. 2002;24:353\u2013359. doi: 10.1081/JDI-120005369.", "ArticleIdList": ["10.1081/JDI-120005369", "12166702"]}, {"Citation": "Linas S.L., Whittenburg D., Repine J.E. Role of xanthine oxidase in ischemia/reperfusion injury. Am. J. Physiol. Physiol. 1990;258:F711\u2013F716. doi: 10.1152/ajprenal.1990.258.3.F711.", "ArticleIdList": ["10.1152/ajprenal.1990.258.3.F711", "2316673"]}, {"Citation": "Zhou J.-Q., Qiu T., Zhang L., Chen Z.-B., Wang Z.-S., Ma X.-X., Li D. Allopurinol preconditioning attenuates renal ischemia/reperfusion injury by inhibiting HMGB1 expression in a rat model. Acta Cir. Bras. 2016;31:176\u2013182. doi: 10.1590/S0102-865020160030000005.", "ArticleIdList": ["10.1590/S0102-865020160030000005", "27050788"]}, {"Citation": "Liyanage T., Ninomiya T., Jha V., Neal B., Patrice H.M., Okpechi I., Zhao M.-h., Lv J., Garg A.X., Knight J., et al. World-wide access to treatment for end-stage kidney disease: A systematic review. Lancet. 2015;385:1975\u20131982. doi: 10.1016/S0140-6736(14)61601-9.", "ArticleIdList": ["10.1016/S0140-6736(14)61601-9", "25777665"]}, {"Citation": "Chen H., Xing B., Liu X., Zhan B., Zhou J., Zhu H., Chen Z. Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur. J. Pharmacol. 2008;581:306\u2013314. doi: 10.1016/j.ejphar.2007.11.050.", "ArticleIdList": ["10.1016/j.ejphar.2007.11.050", "18093583"]}, {"Citation": "Barber E., Men\u00e9ndez S., Le\u00f3n O.S., Barber M.O., Merino N., Calunga J.L., Cruz E., Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediat. Inflamm. 1999;8:37\u201341. doi: 10.1080/09629359990702.", "ArticleIdList": ["10.1080/09629359990702", "PMC1781776", "10704088"]}, {"Citation": "Calunga J.L., Trujillo Y., Zamora Z., Alonso Y., Merino N., Montero T., Men\u00e9ndez S. Ozone oxidative post-conditioning in acute renal failure. J. Pharm. Pharmacol. 2009;61:221\u2013227. doi: 10.1211/jpp.61.02.0012.", "ArticleIdList": ["10.1211/jpp.61.02.0012", "19178770"]}, {"Citation": "Chen H., Xing B., Liu X., Zhan B., Zhou J., Zhu H., Chen Z. Similarities Between Ozone Oxidative Preconditioning and Ischemic Preconditioning in Renal Ischemia/Reperfusion Injury. Arch. Med. Res. 2008;39:169\u2013178. doi: 10.1016/j.arcmed.2007.09.005.", "ArticleIdList": ["10.1016/j.arcmed.2007.09.005", "18164960"]}, {"Citation": "Wang L., Chen Z., Weng X., Wang M., Du Y., Liu X. Combined Ischemic Postconditioning and Ozone Postconditioning Provides Synergistic Protection Against Renal Ischemia and Reperfusion Injury Through Inhibiting Pyroptosis. Urology. 2019;123:296.e1\u2013296.e8. doi: 10.1016/j.urology.2018.10.015.", "ArticleIdList": ["10.1016/j.urology.2018.10.015", "30359711"]}, {"Citation": "Wang Z., Han Q., Guo Y.-L., Liu X.-H., Qiu T. Effect of ozone oxidative preconditioning on inflammation and oxidative stress injury in rat model of renal transplantation. Acta Cir. Bras. 2018;33:238\u2013249. doi: 10.1590/s0102-865020180030000006.", "ArticleIdList": ["10.1590/s0102-865020180030000006", "29668774"]}, {"Citation": "Qiu T., Wang Z.-S., Liu X.-H., Chen H., Zhou J.-Q., Chen Z.-Y., Wang M., Jiang G.-J., Wang L., Yu G., et al. Effect of ozone oxidative preconditioning on oxidative stress injury in a rat model of kidney transplantation. Exp. Ther. Med. 2017;13:1948\u20131955. doi: 10.3892/etm.2017.4193.", "ArticleIdList": ["10.3892/etm.2017.4193", "PMC5443190", "28565792"]}, {"Citation": "Wang L., Chen H., Liu X.-H., Chen Z.-Y., Weng X.-D., Qiu T., Liu L. The protective effect of ozone oxidative preconditioning against hypoxia/reoxygenation injury in rat kidney cells. Ren. Fail. 2014;36:1449\u20131454. doi: 10.3109/0886022X.2014.950934.", "ArticleIdList": ["10.3109/0886022X.2014.950934", "25246346"]}, {"Citation": "Yu L., Gengaro P., Niederberger M., Burke T.J., Schrier R.W. Nitric oxide: A mediator in rat tubularhypoxia/reoxygenation injury. Proc. Natl. Acad. Sci. USA. 1994;91:1691\u20131695. doi: 10.1073/pnas.91.5.1691.", "ArticleIdList": ["10.1073/pnas.91.5.1691", "PMC43229", "7510405"]}, {"Citation": "Tripatara P., Patel N.S., Webb A., Rathod K., Lecomte F.M., Mazzon E., Cuzzocrea S., Yaqoob M.M., Ahluwalia A., Thiemermann C. Nitrite-Derived Nitric Oxide Protects the Rat Kidney against Ischemia/Reperfusion Injury In Vivo: Role for Xanthine Oxidoreductase. J. Am. Soc. Nephrol. 2007;18:570\u2013580. doi: 10.1681/ASN.2006050450.", "ArticleIdList": ["10.1681/ASN.2006050450", "17202421"]}, {"Citation": "Juchau M.R., Chen H. Handbook of Developmental Neurotoxicology. Elsevier; Humana Totowa, NJ, USA: 1998. Developmental Enzymology; pp. 321\u2013337."}, {"Citation": "Demirbag S., Uysal B., Guven A., Cayci T., Ozler M., Ozcan A., Kaldirim U., Surer I., Korkmaz A. Effects of medical ozone therapy on acetaminophen-induced nephrotoxicity in rats. Ren. Fail. 2010;32:493\u2013497. doi: 10.3109/08860221003646352.", "ArticleIdList": ["10.3109/08860221003646352", "20446790"]}, {"Citation": "Reshi M.S., Yadav D., Uthra C., Shrivastava S., Shukla S. Acetaminophen-induced renal toxicity: Preventive effect of silver nanoparticles. Toxicol. Res. 2020;9:406\u2013412. doi: 10.1093/toxres/tfaa040.", "ArticleIdList": ["10.1093/toxres/tfaa040", "PMC7467272", "32905110"]}, {"Citation": "Ucar F., Taslipinar M.Y., Alp B.F., Aydin I., Aydin F.N., Agilli M., Toygar M., Ozkan E., Macit E., Oztosun M., et al. The Effects of N-Acetylcysteine and Ozone Therapy on Oxidative Stress and Inflammation in Acetaminophen-Induced Nephrotoxicity Model. Ren. Fail. 2013;35:640\u2013647. doi: 10.3109/0886022X.2013.780530.", "ArticleIdList": ["10.3109/0886022X.2013.780530", "23560513"]}, {"Citation": "Lewis G., Coughlin L., Jusko W., Hartz S. Contribution of cigarette smoking to cadmium accumulation in man. Lancet. 1972;299:291\u2013292. doi: 10.1016/S0140-6736(72)90294-2.", "ArticleIdList": ["10.1016/S0140-6736(72)90294-2", "4109933"]}, {"Citation": "Vijayakumar V., Abern M., Jagai J., Kajdacsy-Balla A. Observational Study of the Association between Air Cadmium Exposure and Prostate Cancer Aggressiveness at Diagnosis among a Nationwide Retrospective Cohort of 230,540 Patients in the United States. Int. J. Environ. Res. Public Health. 2021;18:8333. doi: 10.3390/ijerph18168333.", "ArticleIdList": ["10.3390/ijerph18168333", "PMC8392592", "34444081"]}, {"Citation": "Singh P., Mitra P., Goyal T., Sharma S., Sharma P. Blood lead and cadmium levels in occupationally exposed workers and their effect on markers of DNA damage and repair. Environ. Geochem. Health. 2020;43:185\u2013193. doi: 10.1007/s10653-020-00696-y.", "ArticleIdList": ["10.1007/s10653-020-00696-y", "32813162"]}, {"Citation": "Ramon D., Morick D., Croot P., Berzak R., Scheinin A., Tchernov D., Davidovich N., Britzi M. A survey of arsenic, mercury, cadmium, and lead residues in seafood (fish, crustaceans, and cephalopods) from the south-eastern Mediterranean Sea. J. Food Sci. 2021;86:1153\u20131161. doi: 10.1111/1750-3841.15627.", "ArticleIdList": ["10.1111/1750-3841.15627", "33580563"]}, {"Citation": "Rani A., Kumar A., Lal A., Pant M. Cellular mechanisms of cadmium-induced toxicity: A review. Int. J. Environ. Health Res. 2013;24:378\u2013399. doi: 10.1080/09603123.2013.835032.", "ArticleIdList": ["10.1080/09603123.2013.835032", "24117228"]}, {"Citation": "Milnerowicz H., \u015aliwi\u0144ska-Mosso\u0144 M., Sobiech K.A. The effect of ozone on the expression of metallothionein in tissues of rats chronically exposed to cadmium. Environ. Toxicol. Pharmacol. 2017;52:27\u201337. doi: 10.1016/j.etap.2017.03.010.", "ArticleIdList": ["10.1016/j.etap.2017.03.010", "28366866"]}, {"Citation": "Ohta H., Qi Y., Ohba K., Toyooka T., Wang R.-S. Role of metallothionein-like cadmium-binding protein (MTLCdBP) in the protective mechanism against cadmium toxicity in the testis. Ind. Health. 2019;57:570\u2013579. doi: 10.2486/indhealth.2018-0177.", "ArticleIdList": ["10.2486/indhealth.2018-0177", "PMC6783288", "30606898"]}, {"Citation": "\u015aliwi\u0144ska-Mosso\u0144 M., Sobiech K., Dolezych B., Madej P., Milnerowicz H. N-acetyl-beta-D-Glucosaminidase in Tissues of Rats Chronically Exposed to Cadmium and Treated with Ozone. Ann. Clin. Lab. Sci. 2019;49:193\u2013203.", "ArticleIdList": ["31028064"]}, {"Citation": "Le Hir M., Dubach U.C., Schmidt U. Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochem. 1979;63:245\u2013251. doi: 10.1007/BF00644546.", "ArticleIdList": ["10.1007/BF00644546", "500408"]}, {"Citation": "Liangos O., Perianayagam M.C., Vaidya V.S., Han W.K., Wald R., Tighiouart H., MacKinnon R.W., Li L., Balakrishnan V.S., Pereira B.J., et al. Urinary N-Acetyl-\u03b2-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure. J. Am. Soc. Nephrol. 2007;18:904\u2013912. doi: 10.1681/ASN.2006030221.", "ArticleIdList": ["10.1681/ASN.2006030221", "17267747"]}, {"Citation": "Boyer M.J., Tannock I.F. Lysosomes, Lysosomal Enzymes, and Cancer. Adv. Cancer Res. 1992;60:269\u2013291.", "ArticleIdList": ["8417501"]}, {"Citation": "\u0141aszczyca P., Kawka-Serweci\u0144ska E., Witas I., Dolezych B., Falkus B., Mekail A., Zi\u00f3\u0142kowska B., Madej P., Migula P. Lipid peroxidation and activity of antioxidative enzymes in the rat model of ozone therapy. Mater. Med. Pol. 1996;28:155\u2013160.", "ArticleIdList": ["9308339"]}, {"Citation": "U.S. Food and Drug Administration (FDA) ADRIAMYCIN (DOXOrubicin HCl) for Injection. FDA; Silver Spring, MD, USA: 2020."}, {"Citation": "Okuda S., Oh Y., Tsuruda H., Onoyama K., Fujimi S., Fujishima M. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int. 1986;29:502\u2013510. doi: 10.1038/ki.1986.28.", "ArticleIdList": ["10.1038/ki.1986.28", "3486312"]}, {"Citation": "Calunga J., Bello M., Chaple M., Barber E., Men\u00e9ndez S., Merino N. Ozonoterapia en la glomerulonefritis t\u00f3xica experimental por adriamicina. Rev. Cuba. Invest. Biomed. 2004;23:139\u2013143."}, {"Citation": "U.S. Food and Drug Administration (FDA). Cisplatin Injection.  [(accessed on 19 October 2022)]; Available online:  https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018057s089lbl.pdf."}, {"Citation": "S\u00e1nchez-Gonz\u00e1lez P.D., L\u00f3pez-Hern\u00e1ndez F.J., Lopez-Novoa J.M., Morales A.I. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit. Rev. Toxicol. 2011;41:803\u2013821. doi: 10.3109/10408444.2011.602662.", "ArticleIdList": ["10.3109/10408444.2011.602662", "21838551"]}, {"Citation": "Jo S.-K., Cho W.Y., Sung S.A., Kim H.K., Won N.H. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 2005;67:458\u2013466. doi: 10.1111/j.1523-1755.2005.67102.x.", "ArticleIdList": ["10.1111/j.1523-1755.2005.67102.x", "15673293"]}, {"Citation": "Ghani M.A., Barril C., Bedgood D.R., Jr., Prenzler P.D. Measurement of antioxidant activity with the thiobarbituric acid reactive substances assay. Food Chem. 2017;230:195\u2013207. doi: 10.1016/j.foodchem.2017.02.127.", "ArticleIdList": ["10.1016/j.foodchem.2017.02.127", "28407901"]}, {"Citation": "Borrego A., Zamora Z.B., Gonz\u00e1lez R., Romay C., Men\u00e9ndez S., Hern\u00e1ndez F., Montero T., Rojas E. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediat. Inflamm. 2004;13:13\u201319. doi: 10.1080/09629350410001664806.", "ArticleIdList": ["10.1080/09629350410001664806", "PMC1781537", "15203559"]}, {"Citation": "Mohamed A.A.-R., Khater S.I., Metwally M.M., Bin Emran T., Nassan M.A., El-Emam M.M.A., Mostafa-Hedeab G., El-Shetry E.S. TGF-\u03b21, NAG-1, and antioxidant enzymes expression alterations in Cisplatin-induced nephrotoxicity in a rat model: Comparative modulating role of Melatonin, Vit. E and Ozone. Gene. 2022;820:146293. doi: 10.1016/j.gene.2022.146293.", "ArticleIdList": ["10.1016/j.gene.2022.146293", "35143943"]}, {"Citation": "Gonz\u00e1lez R., Borrego A., Zamora Z., Romay C., Hern\u00e1ndez F., Men\u00e9ndez S., Montero T., Rojas E. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediat. Inflamm. 2004;13:307\u2013312. doi: 10.1080/09629350400008836.", "ArticleIdList": ["10.1080/09629350400008836", "PMC1781579", "15770045"]}, {"Citation": "Kesik V., Uysal B., Kurt B., Kismet E., Koseoglu V. Ozone ameliorates methotrexate-induced intestinal injury in rats. Cancer Biol. Ther. 2009;8:1623\u20131628. doi: 10.4161/cbt.8.17.9203.", "ArticleIdList": ["10.4161/cbt.8.17.9203", "19617702"]}, {"Citation": "Heyman S.N., Rosenberger C., Rosen S. Regional alterations in renal haemodynamics and oxygenation: A role in contrast medium-induced nephropathy. Nephrol. Dial. Transplant. 2005;20:i6\u2013i11. doi: 10.1093/ndt/gfh1069.", "ArticleIdList": ["10.1093/ndt/gfh1069", "15705946"]}, {"Citation": "Kurtoglu T., Durmaz S., Akgullu C., Gungor H., Eryilmaz U., Meteoglu I., Karul A., Boga M. Ozone preconditioning attenuates contrast-induced nephropathy in rats. J. Surg. Res. 2015;195:604\u2013611. doi: 10.1016/j.jss.2015.01.041.", "ArticleIdList": ["10.1016/j.jss.2015.01.041", "25770741"]}, {"Citation": "Ozturk O., Eroglu H.A., Ustebay S., Kuzucu M., Adali Y. An experimental study on the preventive effects of N-acetyl cysteine and ozone treatment against contrast-induced nephropathy. Acta Cir. Bras. 2018;33:508\u2013517. doi: 10.1590/s0102-865020180060000005.", "ArticleIdList": ["10.1590/s0102-865020180060000005", "30020312"]}, {"Citation": "Mills K.T., Xu Y., Zhang W., Bundy J.D., Chen C.-S., Kelly T.N., Chen J., He J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88:950\u2013957. doi: 10.1038/ki.2015.230.", "ArticleIdList": ["10.1038/ki.2015.230", "PMC4653075", "26221752"]}, {"Citation": "Kalantar-Zadeh K., Jafar T.H., Nitsch D., Neuen B.L., Perkovic V. Chronic kidney disease. Lancet. 2021;398:786\u2013802. doi: 10.1016/S0140-6736(21)00519-5.", "ArticleIdList": ["10.1016/S0140-6736(21)00519-5", "34175022"]}, {"Citation": "Yu G., Bai Z., Chen Z., Chen H., Wang G., Wang G., Liu Z. The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease. Int. Immunopharmacol. 2017;43:203\u2013209. doi: 10.1016/j.intimp.2016.12.022.", "ArticleIdList": ["10.1016/j.intimp.2016.12.022", "28038382"]}, {"Citation": "Calunga J.L., Zamora Z.B., Borrego A., Del R\u00edo S., Barber E., Men\u00e9ndez S., Hern\u00e1ndez F., Montero T., Taboada D. Ozone Therapy on Rats Submitted to Subtotal Nephrectomy: Role of Antioxidant System. Mediat. Inflamm. 2005;2005:221\u2013227. doi: 10.1155/MI.2005.221.", "ArticleIdList": ["10.1155/MI.2005.221", "PMC1526476", "16192672"]}, {"Citation": "Zhao Y.-Y., Feng Y.-L., Bai X., Tan X.-J., Lin R.-C., Mei Q. Ultra Performance Liquid Chromatography-Based Metabonomic Study of Therapeutic Effect of the Surface Layer of Poria cocos on Adenine-Induced Chronic Kidney Disease Provides New Insight into Anti-Fibrosis Mechanism. PLoS ONE. 2013;8:e59617. doi: 10.1371/journal.pone.0059617.", "ArticleIdList": ["10.1371/journal.pone.0059617", "PMC3608665", "23555727"]}, {"Citation": "Chen Z., Liu X., Yu G., Chen H., Wang L., Wang Z., Qiu T., Weng X. Ozone therapy ameliorates tubulointerstitial inflammation by regulating TLR4 in adenine-induced CKD rats. Ren. Fail. 2016;38:822\u2013830. doi: 10.3109/0886022X.2016.1143757.", "ArticleIdList": ["10.3109/0886022X.2016.1143757", "26907800"]}, {"Citation": "Yu G., Liu X., Chen Z., Chen H., Wang L., Wang Z., Qiu T., Weng X. Ozone Therapy Could Attenuate Tubulointerstitial Injury in Adenine-Induced CKD Rats by Mediating Nrf2 and NF-\u039aB. Iran J. Basic Med. Sci. 2016;19:1136\u20131143.", "ArticleIdList": ["PMC5110663", "27872711"]}, {"Citation": "Umanath K., Lewis J.B. Update on Diabetic Nephropathy: Core Curriculum 2018. Am. J. Kidney Dis. 2018;71:884\u2013895. doi: 10.1053/j.ajkd.2017.10.026.", "ArticleIdList": ["10.1053/j.ajkd.2017.10.026", "29398179"]}, {"Citation": "Tuttle K.R., Bakris G.L., Bilous R.W., Chiang J.L., de Boer I.H., Goldstein-Fuchs J., Hirsch I.B., Kalantar-Zadeh K., Narva A.S., Navaneethan S.D., et al. Diabetic Kidney Disease: A Report from an ADA Consensus Conference. Diabetes Care. 2014;37:2864\u20132883. doi: 10.2337/dc14-1296.", "ArticleIdList": ["10.2337/dc14-1296", "PMC4170131", "25249672"]}, {"Citation": "Morsy M.D., Hassan W.N., Zalat S. Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Diabetol. Metab. Syndr. 2010;2:29. doi: 10.1186/1758-5996-2-29.", "ArticleIdList": ["10.1186/1758-5996-2-29", "PMC2880015", "20465785"]}, {"Citation": "G\u00fc\u00e7l\u00fc A., Erken H.A., Erken G., Dodurga Y., Yay A., \u00d6z\u00e7oban \u00d6., \u015eim\u015fek H., Ak\u00e7\u0131lar A., Kocak F.E. The effects of ozone therapy on caspase pathways, TNF-\u03b1, and HIF-1\u03b1 in diabetic nephropathy. Int. Urol. Nephrol. 2015;48:441\u2013450. doi: 10.1007/s11255-015-1169-8.", "ArticleIdList": ["10.1007/s11255-015-1169-8", "26614261"]}, {"Citation": "Varghese R.T., Jialal I. Diabetic Nephropathy.  [(accessed on 9 November 2022)]; Available online:  https://www.ncbi.nlm.nih.gov/books/NBK534200/"}, {"Citation": "Biedunkiewicz B., Tylicki L., Lichodziejewska-Niemierko M., Liberek T., Rutkowski B. Ozonetherapy in a dialyzed patient with calcific uremic arteriolopathy. Kidney Int. 2003;64:367\u2013368. doi: 10.1046/j.1523-1755.2003.00089.x.", "ArticleIdList": ["10.1046/j.1523-1755.2003.00089.x", "12787437"]}, {"Citation": "Di Paolo N., Bocci V., Cappelletti F., Petrini G., Gaggiotti E. Necrotizing Fasciitis Successfully Treated with Extracorporeal Blood Oxygenation and Ozonization (EBOO) Int. J. Artif. Organs. 2002;25:1194\u20131198. doi: 10.1177/039139880202501212.", "ArticleIdList": ["10.1177/039139880202501212", "12518965"]}, {"Citation": "Sancak E.B., Turk\u00f6n H., \u00c7ukur S., Erimsah S., Akbas A., Gulpinar M.T., Toman H., Sahin H., Uzun M. Major Ozonated Autohemotherapy Preconditioning Ameliorates Kidney Ischemia-Reperfusion Injury. Inflammation. 2016;39:209\u2013217. doi: 10.1007/s10753-015-0240-z.", "ArticleIdList": ["10.1007/s10753-015-0240-z", "26282390"]}, {"Citation": "Biedunkiewicz B., Tylicki L., Rachon D., Hak L., Nieweglowski T., Chamienia A., Debska-Slizien A., Mysliwska J., Rutkowski B. Natural Killer Cell Activity Unaffected by Ozonated Autohemotherapy in Patients with End-Stage Renal Disease on Maintenance Renal Replacement Therapy. Int. J. Artif. Organs. 2004;27:766\u2013771. doi: 10.1177/039139880402700906.", "ArticleIdList": ["10.1177/039139880402700906", "15521216"]}, {"Citation": "Tang W.-J., Jiang L., Wang Y., Kuang Z.-M. Ozone therapy induced sinus arrest in a hypertensive patient with chronic kidney disease. Medicine. 2017;96:e9265. doi: 10.1097/MD.0000000000009265.", "ArticleIdList": ["10.1097/MD.0000000000009265", "PMC5815785", "29390373"]}, {"Citation": "Gu X.-B., Yang X.-J., Zhu H.-Y., Xu Y.-Q., Liu X.-Y. Effect of medical ozone therapy on renal blood flow and renal function of patients with chronic severe hepatitis. Chin. Med. J. 2010;123:2510\u20132513.", "ArticleIdList": ["21034619"]}, {"Citation": "Torricelli F.C.M., Danilovic A., Vicentini F., Marchini G.S., Srougi M., Mazzucchi E. Extracorporeal shock wave lithotripsy in the treatment of renal and ureteral stones. Rev. Assoc. Med. Bras. 2015;61:65\u201371. doi: 10.1590/1806-9282.61.01.065.", "ArticleIdList": ["10.1590/1806-9282.61.01.065", "25909212"]}, {"Citation": "U\u011fuz S., Demirer Z., Uysal B., Alp B.F., Malkoc E., Guragac A., Turker T., Ate\u015f F., Karademir K., Ozcan A., et al. Medical ozone therapy reduces shock wave therapy-induced renal injury. Ren. Fail. 2016;38:974\u2013981. doi: 10.3109/0886022X.2016.1172941.", "ArticleIdList": ["10.3109/0886022X.2016.1172941", "27099130"]}, {"Citation": "Madej P., Plewka A., Madej J.A., Nowak M., Plewka D., Franik G., Golka D. Ozonotherapy in an Induced Septic Shock. I. Effect of Ozonotherapy on Rat Organs in Evaluation of Free Radical Reactions and Selected Enzymatic Systems. Inflammation. 2007;30:52\u201358. doi: 10.1007/s10753-007-9021-7.", "ArticleIdList": ["10.1007/s10753-007-9021-7", "17372841"]}, {"Citation": "Madej P., Plewka A., Madej J.A., Plewka D., Mroczka W., Wilk K., Dobrosz Z. Ozone Therapy in Induced Endotoxemic Shock. II. The Effect of Ozone Therapy Upon Selected Histochemical Reactions in Organs of Rats in Endotoxemic Shock. Inflammation. 2007;30:69\u201386. doi: 10.1007/s10753-007-9023-5.", "ArticleIdList": ["10.1007/s10753-007-9023-5", "17458689"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "15"}, {"Year": "2023", "Month": "3", "Day": "5"}, {"Year": "2023", "Month": "3", "Day": "7"}, {"Year": "2023", "Month": "3", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "3", "Day": "29", "Hour": "1", "Minute": "46"}, {"Year": "2023", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["36983907", "PMC10057350", "10.3390/life13030752", "life13030752"]}}], "PubmedBookArticle": []}